期刊
CURRENT PHARMACEUTICAL DESIGN
卷 19, 期 31, 页码 5503-5512出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612811319310006
关键词
Plants; recombinant proteins; glycosylation; glyco-engineering
资金
- Laura Bassi Centres of Expertise (PlantBioP, Austria) [822757]
- Fonds zur Forderung der wissenschaftlichen Forschung FWF, Austria [L575-B13]
- COST Action [FA0804]
Plants are gaining increasingly acceptance as a production platform for recombinant proteins. One reason for this is their ability to carry out posttranslational protein modifications in a similar if not identical way as mammalian cells. The capability of plants to carry out human-like complex glycosylation is well known. Moreover, the targeted manipulation of the plant N-glycosylation pathway allows the production of proteins carrying largely homogeneous, human-type oligosaccharides. These outstanding results have placed plants in a favourable position compared to other eukaryotic expression systems. This review provides a comprehensive summary of the N-glycosylation of plant-produced recombinant proteins, the possible impact of plant-specific N-glycans on the human immune system, and recent advances in engineering the plant N-glycosylation pathway towards the synthesis of (complex) human-type glycan structures, highlighting challenges and achievements in the application of these powerful technologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据